Abstract
Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.
| Original language | English |
|---|---|
| Pages (from-to) | 1341-1343 |
| Number of pages | 3 |
| Journal | BMJ |
| Volume | 340 |
| Issue number | 7760 |
| DOIs | |
| Publication status | Published - 1 Jun 2010 |